Evidence map›Paper›PMID 18615130›Full record

ArticleCurrent neuropharmacology2006

Heterotrimeric g proteins: insights into the neurobiology of mood disorders.

Javier González-Maeso, J Javier Meana

Open access · bronzeAbstract read
In one paragraph

Article in Current neuropharmacology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 29 citations in OpenAlex.

  1. Heteromerization between αPharmacological research · 2021
    Article
  2. Article
  3. Article
  4. Article
  5. Functional coupling of MEuropean archives of psychiatry and clinical neuroscience · 2020
    Article
  6. Selective up-regulation of cannabinoid CBBiochemical pharmacology · 2018
    Article
  7. Article
  8. Review
  9. Article
  10. Enhanced function of prefrontal serotonin 5-HT(2) receptors in a rat model of psychiatric vulnerability.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2010
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Javier González-MaesoDepartment of Neurology, Mount Sinai School of Medicine, New York, NY 10029, USA. Javier.Maeso@mssm.edu
J Javier Meana
Icahn School of Medicine at Mount Sinai · USUniversity of the Basque Country · ES

Funding

HALLUCINOGENS IN SPECIFIC SIGNALING AND CIRCUITRYP01DA012923 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI WEINSTEIN, HAREL · 2000 to 2011
$8.6M
NIDA NIH HHS P01 DA012923
6 · The paper itself

Abstract

Mood disorders such as major depression and bipolar disorder are common, severe, chronic and often life-threatening illnesses. Suicide is estimated to be the cause of death in up to approximately 10-15% of individuals with mood disorders. Alterations in the signal transduction through G protein-coupled receptor (GPCR) pathways have been reported in the etiopathology of mood disorders and the suicidal behavior. In this regard, the implication of certain GPCR subtypes such as alpha(2A)-adrenoceptor has been repeatedly described using different approaches. However, several discrepancies have been recently reported in density and functional status of the heterotrimeric G proteins both in major depression and bipolar disorder. A compilation of the most relevant research topics about the implication of heterotrimeric G proteins in the etiology of mood disorders (i.e., animal models of mood disorders, studies in peripheral tissue of depressive patients, and studies in postmortem human brain of suicide victims with mood disorders) will provide a broad perspective of this potential therapeutic target field. Proposed causes of the discrepancies reported at the level of G proteins in postmortem human brain of suicide victims will be discussed.

Indexed as

bipolar disorderG protein-coupled receptors (GPCR)heterotrimeric G proteinsmajor depressionMood disorderssuicideα2-adrenoceptors

Identifiers

PMID18615130
PMCPMC2430671
OpenAlexW2032985983

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.